Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling-Reference-Cited by-同舟云学术

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

Published:2015-02-02 Issue:3 Volume:125 Page:1129-1146
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Quinn Kylie M.,Zak Daniel E.,Costa Andreia,Yamamoto Ayako,Kastenmuller Kathrin,Hill Brenna J.,Lynn Geoffrey M.,Darrah Patricia A.,Lindsay Ross W.B.,Wang Lingshu,Cheng Cheng,Nicosia Alfredo,Folgori Antonella,Colloca Stefano,Cortese Riccardo,Gostick Emma,Price David A.,Gall Jason G.D.,Roederer Mario,Aderem Alan,Seder Robert A.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference67 articles.

1. A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier

2. Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

3. Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28

4. Replication-Defective Vector Based on a Chimpanzee Adenovirus

5. Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transient inhibition of type I interferon enhances CD8⁺T cell stemness and vaccine protection;2024-06-28

2. Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines;Frontiers in Cellular and Infection Microbiology;2024-06-05

3. B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.S;iScience;2024-05

4. Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses;PLOS ONE;2024-04-16

5. 12.1 In Focus: Novel Manufacturing Platforms for Pandemic Preparedness and Emergency Response;Principles and Practice of Emergency Research Response;2024